Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-28,780
Closed -$3.1M 35
2020
Q1
$3.1M Hold
28,780
1.13% 27
2019
Q4
$4.45M Hold
28,780
1.05% 30
2019
Q3
$4.3M Hold
28,780
1.01% 31
2019
Q2
$4.63M Hold
28,780
1.07% 31
2019
Q1
$4.14M Sell
28,780
-128,935
-82% -$17.2M 0.66% 30
2018
Q4
$18.3M Sell
157,715
-36,120
-19% -$4.38M 3.11% 15
2018
Q3
$25.1M Sell
193,835
-62,410
-24% -$7.49M 3.32% 13
2018
Q2
$25.6M Sell
256,245
-3,305
-1% -$330K 3.22% 14
2018
Q1
$25.5M Buy
+259,550
New +$26.2M 2.96% 14

Other funds holding IQV

M.D. Sass LLC's IQV Position: Q2 2020 in Review

M.D. Sass LLC sold out of IQVIA (IQV) in Q2 2020, closing a stake of 28,780 shares — an estimated $3.1M sold.

M.D. Sass LLC first reported a position in IQV in Q1 2018 and held it in 9 quarters. The position peaked at $25.6M in Q2 2018. 679 funds tracked by Wall St. Rank hold IQV as of Q2 2020.

  • M.D. Sass LLC reported no remaining IQVIA position as of Q2 2020 after selling out during the quarter.
  • M.D. Sass LLC sold 28,780 IQVIA shares in Q2 2020, an estimated $3.1M.
  • M.D. Sass LLC first reported a position in IQVIA in Q1 2018 and held it in 9 quarters.
  • M.D. Sass LLC's IQVIA position peaked at $25.6M in Q2 2018.
  • 679 funds tracked by Wall St. Rank held IQVIA as of Q2 2020.

Based on M.D. Sass LLC's 13F filing for Q2 2020, filed 10 Aug 2020.